MBTD1
Basic information
Region (hg38): 17:51177425-51260163
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MBTD1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 26 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 0 | 0 |
Variants in MBTD1
This is a list of pathogenic ClinVar variants found in the MBTD1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-51180593-T-C | not specified | Uncertain significance (Feb 19, 2025) | ||
17-51180641-G-C | not specified | Uncertain significance (Aug 19, 2024) | ||
17-51180685-A-C | not specified | Uncertain significance (Jun 30, 2023) | ||
17-51192905-T-C | not specified | Uncertain significance (Aug 04, 2024) | ||
17-51192913-C-T | not specified | Uncertain significance (Jul 26, 2022) | ||
17-51192953-G-A | not specified | Uncertain significance (Jul 19, 2023) | ||
17-51192994-C-T | not specified | Uncertain significance (Oct 22, 2021) | ||
17-51193505-T-C | not specified | Uncertain significance (Dec 27, 2023) | ||
17-51201687-C-T | not specified | Uncertain significance (Jan 16, 2025) | ||
17-51202724-A-G | not specified | Uncertain significance (Oct 30, 2024) | ||
17-51202795-T-G | not specified | Uncertain significance (Feb 11, 2022) | ||
17-51202874-C-T | not specified | Uncertain significance (Sep 29, 2022) | ||
17-51202884-C-T | not specified | Uncertain significance (May 17, 2023) | ||
17-51202923-T-C | not specified | Uncertain significance (Aug 09, 2021) | ||
17-51203208-T-C | not specified | Uncertain significance (Jul 12, 2023) | ||
17-51206905-C-T | not specified | Uncertain significance (Oct 26, 2024) | ||
17-51206935-C-T | not specified | Uncertain significance (Oct 01, 2024) | ||
17-51206990-A-T | not specified | Uncertain significance (Jun 16, 2024) | ||
17-51207004-G-A | not specified | Uncertain significance (May 17, 2023) | ||
17-51217371-T-C | not specified | Uncertain significance (Jul 26, 2024) | ||
17-51217377-T-C | not specified | Uncertain significance (Jan 04, 2025) | ||
17-51217378-T-G | not specified | Uncertain significance (Jan 24, 2025) | ||
17-51218938-G-A | not specified | Uncertain significance (Jan 31, 2024) | ||
17-51218959-G-A | not specified | Uncertain significance (Apr 20, 2024) | ||
17-51225062-T-C | not specified | Uncertain significance (Dec 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MBTD1 | protein_coding | protein_coding | ENST00000586178 | 15 | 82739 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 9.56e-7 | 125686 | 0 | 1 | 125687 | 0.00000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.45 | 150 | 325 | 0.462 | 0.0000164 | 4136 |
Missense in Polyphen | 31 | 106.48 | 0.29114 | 1351 | ||
Synonymous | 0.847 | 99 | 110 | 0.897 | 0.00000609 | 1140 |
Loss of Function | 5.76 | 0 | 38.6 | 0.00 | 0.00000218 | 458 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins maintain the transcriptionally repressive state of genes, probably via a modification of chromatin, rendering it heritably changed in its expressibility (By similarity). Specifically binds to monomethylated and dimethylated 'Lys-20' on histone H4. {ECO:0000250, ECO:0000269|PubMed:19841675}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving MBTD1 is a cause of acute poorly differentiated myeloid leukemia. Translocation (10;17)(p15;q21) with ZMYND11. {ECO:0000269|PubMed:23915195}.;
- Pathway
- Mesodermal Commitment Pathway
(Consensus)
Recessive Scores
- pRec
- 0.0830
Intolerance Scores
- loftool
- 0.119
- rvis_EVS
- 0.06
- rvis_percentile_EVS
- 58.53
Haploinsufficiency Scores
- pHI
- 0.360
- hipred
- Y
- hipred_score
- 0.731
- ghis
- 0.541
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.943
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mbtd1
- Phenotype
- craniofacial phenotype; skeleton phenotype; liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype;
Gene ontology
- Biological process
- chromatin organization;regulation of transcription, DNA-templated;embryonic skeletal system development
- Cellular component
- nucleus
- Molecular function
- zinc ion binding;methylated histone binding